Atrial Fibrillation with Rapid Ventricular Response in Sepsis: Guideline Summary

Introduction to Rate Control

The European Society of Cardiology recommends that digoxin is ineffective for acute rate control in high sympathetic states, which characterizes sepsis, due to its reduced efficacy during conditions of elevated catecholamine activity 1, 2
The American College of Cardiology suggests that digoxin has a delayed onset of action, requiring at least 60 minutes before any therapeutic effect, with peak effect not occurring until 6 hours, which is far too slow for acute management 1, 2

The American Heart Association recommends beta-blockers as the initial treatment choice for AF with RVR during sepsis, even in critically ill patients, due to their association with superior clinical outcomes 3, 4
The American College of Cardiology suggests that esmolol is preferred for titratability in hemodynamically unstable patients 3
The Journal of the American College of Cardiology recommends exercising caution but not automatically excluding patients with overt congestion or hypotension, as the data support beta-blocker use even in vasopressor-dependent shock 4

The American College of Cardiology recommends that digoxin may have a role only in specific circumstances where beta-blockers are contraindicated or as adjunctive therapy, such as in patients with severe LV systolic dysfunction with heart failure (Class I, Level B) 5, 3, 4
The American Heart Association suggests that combination of digoxin plus beta-blocker is reasonable for rate control when beta-blocker alone is insufficient (Class IIa, Level B) 5, 3, 4

The American College of Cardiology recommends that absolute contraindications to digoxin include second- or third-degree heart block without permanent pacemaker, pre-excitation syndromes (WPW), and known digoxin intolerance 6, 5, 1, 2
The Journal of the American College of Cardiology suggests that high-risk situations requiring extreme caution include hypokalemia and hypomagnesemia, renal impairment, hypothyroidism, and acute myocardial infarction 6, 3, 2

The American Heart Association recommends mandatory serial monitoring of serum potassium and magnesium, renal function, digoxin level, and continuous cardiac monitoring for arrhythmias if digoxin is used 6
The American College of Cardiology suggests that drug interactions requiring 50% dose reduction include amiodarone, diltiazem, verapamil, certain antibiotics, and quinidine 6